Position in ARGX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$867,464
+$184,681 QoQ
Shares Held
935
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#62
of 179 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crews Bank & Trust holds $920,984 across 7 Biotechnology names. ARGX ranks #1 (94.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
935 | $867,464 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
300 | $16,500 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
1,800 | $15,759 | |
| 4 | MNKD |
Mannkind Corp
|
2,648 | $11,280 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12 | $5,960 | |
| 6 | LEXX |
Lexaria Bioscience Corp.
|
3,864 | $2,163 | |
| 7 | ACRV |
Acrivon Therapeutics, Inc.
|
1,044 | $1,858 |
All Filings in ARGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $867,464 | 935 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $682,783 | 935 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $786,288 | 935 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $689,618 | 935 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $515,390 | 935 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $553,393 | 935 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $575,025 | 935 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||